Colzyx

Colzyx

Colzyx's WOUNDCOM is a new category of bioactive wound dressings. It mimics natural body mechanisms and, at the same time, combat bacterial infection.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round

€1.0m

Convertible
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth25 %(43 %)(27 %)---1 %
EBITDA0000000000000000000000000000
Profit0000000000000000000000000000
% profit margin7 %(40 %)(1104 %)--(65 %)(60 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Notes (0)
More about Colzyx
Made with AI
Edit

Developer of bioactive wound care products intended to combat multidrug-resistant bacteria. The company's product utilizes molecules derived from human collagen in combination with a biomembrane to treat active and chronic wounds and accelerates wound healing while having an antibacterial effect, enabling customers to obtain rapid wound closure, and decrease bacterial wound and infections.

Keywords: Pharmaceuticals and Biotechnology, Antimicrobial Products, Biotechnology Company, Chronic Wounds Care, Healing Wound, Wound Care Product, Wound Care Supplies.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo